Algert Global LLC Has $3.58 Million Holdings in Oscar Health, Inc. (NYSE:OSCR)

Algert Global LLC raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 46.4% in the second quarter, Holdings Channel reports. The institutional investor owned 226,339 shares of the company’s stock after buying an additional 71,706 shares during the quarter. Algert Global LLC’s holdings in Oscar Health were worth $3,581,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of OSCR. Dimensional Fund Advisors LP lifted its holdings in shares of Oscar Health by 14.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,162,935 shares of the company’s stock worth $28,942,000 after buying an additional 392,837 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Oscar Health by 530.1% during the fourth quarter. Principal Financial Group Inc. now owns 141,919 shares of the company’s stock worth $1,299,000 after buying an additional 119,397 shares during the last quarter. TD Asset Management Inc lifted its holdings in shares of Oscar Health by 71.9% during the fourth quarter. TD Asset Management Inc now owns 195,600 shares of the company’s stock worth $1,790,000 after buying an additional 81,800 shares during the last quarter. Focus Financial Network Inc. ADV acquired a new position in shares of Oscar Health during the fourth quarter worth approximately $152,000. Finally, NEOS Investment Management LLC acquired a new position in shares of Oscar Health during the fourth quarter worth approximately $205,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Stock Performance

Oscar Health stock opened at $21.21 on Tuesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a fifty day moving average price of $18.60 and a two-hundred day moving average price of $17.89. Oscar Health, Inc. has a 52-week low of $4.72 and a 52-week high of $23.79. The firm has a market capitalization of $5.03 billion, a P/E ratio of -53.03, a P/E/G ratio of 43.01 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. During the same period in the prior year, the company posted ($0.07) earnings per share. The business’s revenue for the quarter was up 44.6% compared to the same quarter last year. As a group, analysts anticipate that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on OSCR shares. Wells Fargo & Company upped their target price on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Piper Sandler restated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Oscar Health presently has an average rating of “Moderate Buy” and a consensus target price of $24.17.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Ranmali Bopitiya sold 36,175 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $650,788.25. Following the sale, the executive vice president now owns 251,885 shares in the company, valued at $4,531,411.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. The disclosure for this sale can be found here. Insiders sold 169,569 shares of company stock worth $3,007,069 over the last three months. 25.11% of the stock is currently owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.